Project Number 2020_Amylyx Agency/Funding Organization Cure Alzheimer's Fund Funding Year 2020 View Full Project Details for PEGASUS Clinical Study of AMX0035 in Alzheimer’s Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 8. Late-stage Clinical Drug Development (Phase II/III and III Clinical Trials) g. Oxidative Stress Researcher and Organization Principal Investigator Amylyx Principal Investigator Amylyx Awardee Organization Amylyx Pharma Awardee State Massachusetts Contact PI Country United States Project Detail FY Overall Cost $100,000 Funding Organization Agency/Funding Organization Cure Alzheimer's Fund Funding Organization Country United States
